Tag: biotechnology
-
Clinical Trial Underway for One-Time Crispr HIV Treatment
A clinical trial is underway assessing a therapy for HIV infections that aims to eradicate the virus with one dose of the gene-editing technique Crispr.
-
Science/Tech AI Developer Raises $100M in New Funds
A provider of artificial intelligence services for scientific and advanced technology applications is raising $100 million in its second venture round.
-
Exosomes Shown to Block Broad Covid-19 Variant Range
Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells.
-
Trial Shows Immunotherapy Improves Lung Cancer Survival
Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy.
-
Genetics Help Control Dangerous Insects
Advances in genetics are providing communities, businesses, and homeowners with new tools for controlling harmful insects.
-
Biotech, AI Company Partner on Covid-19 Alert System
A developer of Covid-19 vaccines and an artificial intelligence company are building a system to quickly detect dangerous SARS-CoV-2 variants.
-
Biotech Partners on Gene Editing Tech in $1.35B Deal
A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion.
-
Sanofi Partners in $5.3B Precision Drug Discovery Deal
A company using artificial intelligence to design drugs for personalized treatments is partnering with drug maker Sanofi in a deal valued at $5.3 billion.
-
Trial Set for Covid-19 Nasal Spray Vaccine
A clinical trial testing a vaccine to protect against Covid-19 disease, given as a nasal spray, is scheduled to begin later this year in the Netherlands.
-
Optogenetics Start-Up Raises $6M for Retinal Therapy
A new company developing a therapy using light-sensitive proteins for treating an inherited eye disorder is raising $6 million in seed funds.